1-(3-(9H-carbazol-9-yl)-1-propyl)-4-(2-methoxyphenyl)-4-piperidinol, a novel subtype selective inhibitor of the mouse type II GABA-transporter

British Journal of Pharmacology

Volumn 120, Issue 6, 1997, Pages 983-985

  Thomsen, Christian ^a   Sørensen, Per Olaf ^a   Egebjerg, Jan ^a,b  

^a NOVO NORDISK A S   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

Author keywords

aminobutyric acid (GABA) uptake; (NNC 05 2090); 1 (3 (9H carbazol 9 yl) 1 propyl) 4 (2 methoxyphenyl) 4 piperidinol; BGT 1; Lipophilic GABA uptake inhibitor; Tiagabine

Indexed keywords

1 (3 (9H CARBAZOL 9 YL) 4 (2 METHOXYPHENYL) 4 PIPERIDINOL; 1 [3 (9H CARBAZOL 9 YL)PROPYL] 4 (2 METHOXYPHENYL) 4 PIPERIDINOL; PIPERIDONE DERIVATIVE; TIAGABINE; UNCLASSIFIED DRUG;

4 AMINOBUTYRIC ACID UPTAKE; ANIMAL CELL; ARTICLE; BRAIN; CELL STRAIN BHK; CONTROLLED STUDY; GABAERGIC TRANSMISSION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; CARRIER PROTEINS; CELL LINE; CRICETINAE; GABA PLASMA MEMBRANE TRANSPORT PROTEINS; GAMMA-AMINOBUTYRIC ACID; MEMBRANE PROTEINS; MEMBRANE TRANSPORT PROTEINS; MICE; NEUROTRANSMITTER UPTAKE INHIBITORS; NIPECOTIC ACIDS; ORGANIC ANION TRANSPORTERS; PIPERIDINES; PROLINE;

EID: 0030955132     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0700957     Document Type: Article

References (8)

1. BORDEN, L.A., DHAR, T.G.M., SMITH, K.E., WEINSHANK, R.L., BRANCHEK, T.A. & GLUCHOWSKI, C. (1994). Tiagabine, SK&F 89976-A, CI-966 and NNC-711 are selective for the cloned GABA transporter GAT-1. Eur. J. Pharmacol. Mol. Pharmacol., 269, 219-224.
2. BORDEN, L.A., SMITH, K.E., VAYSSE, P.J.-J., GUSTAFSON, E.L., WEINSHANK, R.L. & BRANCHEK, T.A. (1995). Re-evaluation of GABA transport in neuronal and glial cell cultures: correlation of pharmacology and mRNA localization. Receptors and Channels, 3, 129-146.
3. DHAR, T.G.M., BORDEN, L.A., TYAGARAJAN, S., SMITH, K.E., BRANCHEK, T.A., WEINSHANK, R.L. & GLUCHOWSKI, C. (1994). Design, synthesis and evaluation of substituted triarylnipecotic acid derivatives as GABA uptake inhibitors: Identification of a ligand with moderate affinity and selectivity for the cloned human GABA transporter GAT-3. J. Med. Chem., 37, 2334-2342.
4. FOSTER, D.C., HOLLY, R.D., SPRECHER, C.A., WALKER, K.M. & KUMAR, A.A. (1991). Endoproteolytic processing of the human protein C precursor by the yeast Kex2 endopeptidase coexpressed in mammalian cells. Biochemistry, 30, 367-372.
5. KROGSGAARD-LARSEN, P., FALCH, E., LARSSON, O.M. & SCHOUSBOE, A. (1987). GABA uptake inhibitors: relevance to antiepileptic drug research. Epilepsy Res., 1, 77-93.
6. LIU, Q.-R., LOPEZ-CORCUERA, B., MANDIYAN, S., NELSON, H. & NELSON, N. (1993). Molecular characterization of four pharmacologically distinct α-aminobutyric acid transporters in mouse brain. J. Biol. Chem., 268, 2106-2112.
7. SUZDAK, P. (1993). Lipophilic GABA uptake inhibitors: biochemistry, pharmacology and therapeutic potential. Drugs of the Future, 18, 1129-1136.
8. UHL, G.R. & HARTIG, P.R. (1992). Transporter explosion: update on uptake. Trends Pharmacol. Sci., 13, 421-425.